A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673) Administered to Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/141/1/17

Funding

  • Medivation